Literature DB >> 15240745

Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.

Margaret R Gyetko1, David Aizenberg, Laura Mayo-Bond.   

Abstract

Leukocytes express both urokinase-type plasminogen activator (uPA) and the urokinase receptor (uPAR, CD87). We have shown that neutrophil recruitment to the lung during P. aeruginosa pneumonia is impaired in uPAR-deficient (uPAR-/-) mice but is normal in uPA-/- mice. However, both uPA-/- mice and uPAR-/- mice have impaired lung clearance of P. aeruginosa compared with wild-type (WT) mice. To determine the role of uPA and uPAR in antibacterial host defense, we compared neutrophil bacterial-phagocytosis, respiratory burst, and degranulation among uPA-/-, uPAR-/-, and WT mice. Neutrophil phagocytosis was significantly diminished comparing uPA-/- and uPAR-/- mice with WT mice at all time points. The generation of superoxide by both uPA-/- and uPAR-/- neutrophils was about half of that seen in WT neutrophils. Degranulation of azurophilic granules was significantly diminished in uPA-/- neutrophils compared with either uPAR-/- or WT neutrophils. By contrast, agonist-stimulated release of specific granules was not diminished in either uPA-/- or uPAR-/- mice compared with WT. We conclude that the uPA/uPAR system modulates several of the crucial steps in neutrophil activation that result in bacterial killing and effective innate host defense.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240745     DOI: 10.1189/jlb.0104023

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

1.  Regulation of urokinase expression at the posttranscription level by lung epithelial cells.

Authors:  Shwetha K Shetty; Amarnath S Marudamuthu; Daniel Abernathy; Rashmi S Shetty; Praveenkumar Shetty; Jian Fu; Steven Idell; Yashodhar P Bhandary; Honglong Ji; Ming-Cheh Liu; Sreerama Shetty
Journal:  Biochemistry       Date:  2011-12-23       Impact factor: 3.162

2.  Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Authors:  Julie M Leth; Haydyn D T Mertens; Katrine Zinck Leth-Espensen; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

3.  Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.

Authors:  Aurelia Lugea; Li Nan; Samuel W French; Jorge A Bezerra; Anna S Gukovskaya; Stephen J Pandol
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

4.  Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.

Authors:  Shinsuke Yasuda; Nasa Morokawa; G William Wong; Andrea Rossi; Mallur S Madhusudhan; Andrej Sali; Yuko S Askew; Roberto Adachi; Gary A Silverman; Steven A Krilis; Richard L Stevens
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

5.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

6.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Authors:  Andrew D Cook; Christine M De Nardo; Emma L Braine; Amanda L Turner; Ross Vlahos; Kerrie J Way; S Kaye Beckman; Jason C Lenzo; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

7.  The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis.

Authors:  Dominique Leduc; Nathalie Beaufort; Sophie de Bentzmann; Jean-Claude Rousselle; Abdelkader Namane; Michel Chignard; Dominique Pidard
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

8.  Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.

Authors:  Serena Boccella; Elisabetta Panza; Liliana Lista; Carmela Belardo; Angela Ianaro; Mario De Rosa; Vito de Novellis; Vincenzo Pavone
Journal:  Inflamm Res       Date:  2017-04-29       Impact factor: 4.575

9.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

10.  The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications.

Authors:  Chantal Fradin; Abigail L Mavor; Günther Weindl; Martin Schaller; Karin Hanke; Stefan H E Kaufmann; Hans Mollenkopf; Bernhard Hube
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.